In glioma cell lines, genetic inhibition of ERK5 decreases HGF-induced cell migration and invasiveness in vitro and reduces the expression of the mesenchymal marker N-cadherin and CD44, which are associated with glioma invasiveness. The gene discussed is HGF; the disease is central nervous system cancer.